On this basis, it can be hypothesized that RNF185, in a COL3A1-dependent manner, may act as a tumor suppressor in a broad spectrum of cancers; consequently, it may be targeted for the development of therapeutic strategies for different tumors. This evidence concerns the gene RNF185 and neoplasm.